November 30, 2020 – Winnipeg Manitoba. Research Manitoba and Boehringer Ingelheim (Canada) Ltd. are excited to announce a new partnership, with the creation of the Boehringer Ingelheim-Research Manitoba (BI-RM) Partnership Fund. The fund will support community-based research and innovation projects focused on improving diabetes health outcomes within Indigenous communities in Manitoba.
Support from the BI-RM Partnership Fund will align with the province of Manitoba’s Shared Health Clinical and Preventative Services Plan, and Boehringer Ingelheim Canada’s PATHWAYS – Indigenous Health Collaborations, a partnership established with Bimaadzwin intended to empower Indigenous communities in improving health and wellness.
“We are very excited about entering into this collaboration with our renowned partner, Boehringer Ingelheim Canada, to provide support for Indigenous-led projects to improve health systems and patient care in their communities,” said Sean McKay, Interim CEO, Research Manitoba. “This is the second of what we anticipate to be many collaborations through Research Manitoba’s recently launched Strategic Partnerships Program that aims to leverage relationships and funding to significantly increase the amount of research carried out in Manitoba for the benefit of the community at large.”